 Investment analysts at Needham Company LLC began coverage on shares of Collegium Pharmaceutical NASDAQ:COLL in a research report issued on Monday, TipRanks reports. The firm set a buy rating and a 36.00 price target on the specialty pharmaceutical companys stock. Needham Company LLCs target price indicates a potential upside of 105.25 from the ... 